Search Login Register

Lipodystrophy Summary

Description: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.

Also Known As: Lipodystrophies

Networked: 1655 relevant articles (75 outcomes, 170 trials/studies) for this Disease

Key Drugs and Agents for Lipodystrophy

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Leptin : 15 outcomes 24 studies in 122 results : IBA
  2. Insulin (Novolin) : 12 outcomes 12 studies in 215 results : FDA 2
  3. Glucose (Dextrose) : 5 outcomes 10 studies in 112 results : FDA 175 Generic
  4. tesamorelin : 3 outcomes 2 studies in 10 results : FDA 1
  5. Protease Inhibitors (Protease Inhibitor) : 2 outcomes 13 studies in 182 results : IBA
  6. Mitochondrial DNA (mtDNA) : 2 outcomes 3 studies in 27 results : IBA
  7. Nevirapine (Viramune) : 2 outcomes 3 studies in 15 results : FDA 29
  8. Ritonavir (Norvir) : 2 outcomes 2 studies in 21 results : FDA 11
  9. Lipids : 2 outcomes 2 studies in 21 results : IBA
  10. Thymidine : 2 outcomes 2 studies in 13 results : IBA
Show All >>

Diseases Related to Lipodystrophy

  1. Insulin Resistance
  2. HIV Infections (HIV Infection)
  3. Dyslipidemias (Dyslipidemia)
  4. Acquired Immunodeficiency Syndrome (AIDS)
  5. Hyperinsulinism (Hyperinsulinemia)
Show All >>

Key Therapies for Lipodystrophy

Efficacy Chart >>
  1. Highly Active Antiretroviral Therapy (HAART) : 13 outcomes 34 studies in 342 results
  2. Lipectomy (Liposuction) : 3 outcomes 1 study in 40 results
  3. Caloric Restriction : 2 outcomes 1 study in 2 results
  4. Drug Therapy (Chemotherapy) : 1 outcome 1 study in 13 results
  5. Meditation : 1 outcome in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.